Status:
UNKNOWN
Analysis of Volatile Organic Compounds in the Exhaled Air in Inflammatory Bowel Disease
Lead Sponsor:
Keimyung University Dongsan Medical Center
Conditions:
Volatile Organic Compounds
Inflammatory Bowel Disease
Eligibility:
All Genders
18-80 years
Brief Summary
The availability of noninvasive biomarkers for diagnosis and stratification of inflammatory bowel disease (IBD) courses is lacking. Thus, the aim of this study is to evaluated the accuracy of exhaled ...
Detailed Description
Background: The diagnosis and differentiation of inflammatory bowel diseases (IBD) is challenging due to the absence of a gold standard diagnostic modality for confirmation. Exhaled breath volatile me...
Eligibility Criteria
Inclusion
- Patients with inflammatory bowel disease (Crohn's disease or ulcerative colitis)
- Healthy controls who do not have any gastrointestinal disease or symptom
Exclusion
- Pregnant or lactating woman
- Subjects who diagnosed liver cirrhosis, severe congestive heart failure, severe renal insufficiency, uncontrolled hypertension, endocrine disorder, metabolic disorder, prior malignancy, immune deficiency
- Subjects with mental retardation and cognitive impairment
Key Trial Info
Start Date :
February 20 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03414580
Start Date
February 20 2018
End Date
June 1 2021
Last Update
September 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KeimyungUniversity
Daegu, Jung-gu, South Korea, 700-712